MARKETMOVERS : Irish stocks not immune to global shake-out

Irish Independent - Dublin,Ireland
Pharma company Elan rose by a very healthy 18pc on fresh speculation of an imminent approval for Tysabri. Elan stood out as a share which performed well. ...

Elan Corp. Chugs Higher on Tysabri Strength
Ant & Sons - USA
... neurodegenerative diseases. On the strength of its main drug for multiple sclerosis Tysabri, Elan continues to chug higher. On Friday ...